agilon health, inc.
AGL
$86.39
$5.827.22%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 125.90% | -- | -- | -961.71% | 111.45% |
| Total Depreciation and Amortization | 200.83% | -- | -- | 6.44% | 271.64% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -129.92% | -- | -- | 174.63% | -222.42% |
| Change in Net Operating Assets | -110.20% | -- | -- | 236.30% | -136.68% |
| Cash from Operations | 215.54% | -- | -- | -9.69% | -294.82% |
| Capital Expenditure | -4.48% | -- | -- | 15.56% | -17.85% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.44% | -- | -- | 483.10% | -171.42% |
| Cash from Investing | -14.66% | -- | -- | 405.16% | -197.53% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -9,588.24% | -- | -- | -1,502.48% | -- |
| Cash from Financing | -30,176.47% | -- | -- | -1,502.48% | -631.82% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,765.60% | -- | -- | 159.37% | -237.85% |